Abbott’s HUMIRA® (adalimumab) receives U.S. FDA approval for the treatment of adult patients with moderate to severe ulcerative colitis
The U.S. FDA has approved HUMIRA®...
28 September 2012 | By Abbott
The U.S. FDA has approved HUMIRA®...
List view / Grid view
The U.S. FDA has approved HUMIRA®...
28 September 2012 | By Abbott
The U.S. FDA has approved HUMIRA®...
The European Commission has approved HUMIRA®...
11 April 2012 | By
The European Commission has approved HUMIRA®...